A SPAC III Acquisition Corp. (ASPCU) Prices $55M IPO
by Nicholas Alan Clayton on 2024-11-08 at 9:29am

A SPAC III Acquisition Corp. (NASDAQ:ASPCU) announced the pricing of its $55 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ASPCU”, Friday, November 8, 2024.

The new SPAC intends to seek out a target company with strong ESG principals in the material technology sector with potential for recurring revenue and cash flow.

A SPAC III is led by Chief Executive Officer, Chief Financial Officer and Chairman Claudius Tsang. The Board also includes Xiangge Liu, Wong Yi Dung Eden and Pang Wai Yuen Marvin.

Total SPAC deal count for 2024 year-to-date is now 46. This offering is expected to close on Monday, November 11, 2024.


Maxim Group LLC is acting as the sole book-running manager for the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. WWC, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2024-12-24 at 2:07pm

Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...

by Nicholas Alan Clayton on 2024-12-24 at 8:13am

At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...

by Nicholas Alan Clayton on 2024-12-23 at 3:40pm

Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...

by Kristi Marvin on 2024-12-23 at 10:52am

Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...

by Nicholas Alan Clayton on 2024-12-23 at 8:18am

At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved